173 related articles for article (PubMed ID: 3512457)
1. Effects of cyclosporin A, antilymphocyte serum and donor-specific transfusions on murine delayed-type hypersensitivity and skin graft survival.
Mottram PL; Mirisklavos A; Dumble LJ; Clunie GJ
Int Arch Allergy Appl Immunol; 1986; 79(3):296-304. PubMed ID: 3512457
[TBL] [Abstract][Full Text] [Related]
2. Late adjunctive therapy with single doses of rapamycin in skin-allografted mice treated with antilymphocyte serum and donor bone marrow cells.
De Fazio SR; Plowey JM; Hartner WC; Gozzo JJ
Transpl Immunol; 1996 Jun; 4(2):105-12. PubMed ID: 8843586
[TBL] [Abstract][Full Text] [Related]
3. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells). Is in vivo cell transferrable?
Perez M; Lobo FM; Yamane Y; John L; Berger CL; Edelson RL
Ann N Y Acad Sci; 1991 Dec; 636():95-112. PubMed ID: 1793234
[TBL] [Abstract][Full Text] [Related]
5. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
Hale DA; Gottschalk R; Maki T; Monaco AP
Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
[TBL] [Abstract][Full Text] [Related]
6. T suppressor cells induced by transfusions and cyclosporine. Studies in the murine cardiac allograft model.
Mottram PL; Mirisklavos A; Dumble LJ; Clunie GJ
Transplantation; 1990 Dec; 50(6):1033-7. PubMed ID: 2147790
[TBL] [Abstract][Full Text] [Related]
7. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice.
Ohzato H; Monaco AP
Transplantation; 1992 Dec; 54(6):1090-5. PubMed ID: 1465774
[TBL] [Abstract][Full Text] [Related]
8. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
Yuh DD; Morris RE
Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226
[TBL] [Abstract][Full Text] [Related]
9. Induction of allograft tolerance with neonatal skin.
Jamshidi F; De Fazio SR; Markees TG; Gozzo JJ
Transplantation; 1991 May; 51(5):1048-52. PubMed ID: 2031261
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes.
Perez M; Edelson R; Laroche L; Berger C
J Invest Dermatol; 1989 May; 92(5):669-76. PubMed ID: 2523941
[TBL] [Abstract][Full Text] [Related]
11. Allograft and xenograft unresponsiveness induced by transplantation of neonatal skin.
Jamshidi F; De Fazio SR; Gozzo JJ
Transplantation; 1993 Jul; 56(1):135-8. PubMed ID: 8333035
[TBL] [Abstract][Full Text] [Related]
12. Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow.
Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
Transplantation; 1997 Feb; 63(3):359-64. PubMed ID: 9039923
[TBL] [Abstract][Full Text] [Related]
13. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus.
Fukuzaki T; Hancock WW; Monaco AP; Maki T
Transplantation; 1998 Apr; 65(8):1036-43. PubMed ID: 9583862
[TBL] [Abstract][Full Text] [Related]
14. The effect of timing of multiple donor-specific or nonspecific blood transfusions on skin allograft survival in ALS-treated mice.
Wood ML; Gottschalk R; Monaco AP
Transplantation; 1983 Oct; 36(4):388-91. PubMed ID: 6353706
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine and murine responses to alloantigens: effects of cyclosporine and donor-specific transfusions on delayed hypersensitivity reactions and murine skin allografts.
Mottram PL; Mirisklavos A; Clunie GJ
Transplant Proc; 1985 Apr; 17(2):1646-9. PubMed ID: 3885498
[No Abstract] [Full Text] [Related]
16. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
[TBL] [Abstract][Full Text] [Related]
17. T-cell mediated responses in a murine model of orthotopic corneal transplantation.
Joo CK; Pepose JS; Stuart PM
Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1530-40. PubMed ID: 7601633
[TBL] [Abstract][Full Text] [Related]
18. The effect of antilymphocyte serum, fractionated donor bone marrow, and cyclosporine on renal allograft survival in mongrel dogs.
Hartner WC; Markees TG; De Fazio SR; Khouri W; Maki T; Monaco AP; Gozzo JJ
Transplantation; 1991 Nov; 52(5):784-9. PubMed ID: 1835194
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells).
Perez MI; Edelson RL; John L; Laroche L; Berger CL
Yale J Biol Med; 1989; 62(6):595-609. PubMed ID: 2636801
[TBL] [Abstract][Full Text] [Related]
20. Patterns of allosensitization in allograft recipients: long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity.
VanBuskirk AM; Wakely ME; Sirak JH; Orosz CG
Transplantation; 1998 Apr; 65(8):1115-23. PubMed ID: 9583874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
